• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素抵抗对雌激素治疗的个体剂量反应。

Individual dose response of insulin resistance to estrogen therapy.

作者信息

Jovanovic Kevin, Taylor Hugh S

机构信息

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520-8063, USA.

出版信息

J Reprod Med. 2007 Aug;52(8):667-9.

PMID:17879825
Abstract

OBJECTIVE

To determined the dose response of insulin resistance (IR) to estrogen in individual patients.

STUDY DESIGN

Eighteen subjects meeting inclusion criteria were enrolled, and 9 completed the study. Each subject was treated for 3 months with 0.3, 0.625 and 1.25 mg of conjugated equine estrogens (CEE) in random order, for a total of 9 months of treatment. Fasting serum insulin and glucose levels were obtained.

RESULTS

The fasting glucose/insulin ratio and quantitative insulin-sensitivity check index (QUICKI) were calculated. No significant change was noted in either parameter with any dose of CEE in a single subject.

CONCLUSION

This was the first study to examine the dose response of IR to estrogen using paired measurements from individuals. IR does not vary in individuals when doses of estrogen are altered.

摘要

目的

确定个体患者中胰岛素抵抗(IR)对雌激素的剂量反应。

研究设计

招募了18名符合纳入标准的受试者,其中9名完成了研究。每位受试者按随机顺序接受0.3、0.625和1.25毫克结合马雌激素(CEE)治疗3个月,总共治疗9个月。获取空腹血清胰岛素和血糖水平。

结果

计算空腹血糖/胰岛素比值和定量胰岛素敏感性检查指数(QUICKI)。在单个受试者中,任何剂量的CEE均未使这两个参数发生显著变化。

结论

这是第一项使用个体配对测量来研究IR对雌激素剂量反应的研究。当改变雌激素剂量时,个体的IR没有变化。

相似文献

1
Individual dose response of insulin resistance to estrogen therapy.胰岛素抵抗对雌激素治疗的个体剂量反应。
J Reprod Med. 2007 Aug;52(8):667-9.
2
Effects of tibolone and conjugated equine estrogens with or without medroxyprogesterone acetate on body composition and fasting carbohydrate measures in surgically postmenopausal monkeys.替勃龙及结合马雌激素联合或不联合醋酸甲羟孕酮对手术绝经后猴子身体成分和空腹碳水化合物指标的影响
Metabolism. 2003 Sep;52(9):1085-91. doi: 10.1016/s0026-0495(03)00181-1.
3
Predictors of worsening insulin sensitivity in postmenopausal women.绝经后女性胰岛素敏感性恶化的预测因素。
Am J Obstet Gynecol. 2006 Feb;194(2):355-61. doi: 10.1016/j.ajog.2005.07.046.
4
Insulin resistance and body composition in Turner syndrome: Effect of sequential change in the route of estrogen administration.特纳综合征中的胰岛素抵抗与身体组成:雌激素给药途径顺序变化的影响
Gynecol Endocrinol. 2006 Oct;22(10):590-4. doi: 10.1080/08916930600929586.
5
Addition of medroxyprogesterone acetate to conjugated equine estrogens results in insulin resistance in adipose tissue.在结合马雌激素中添加醋酸甲羟孕酮会导致脂肪组织出现胰岛素抵抗。
Metabolism. 2007 Jun;56(6):830-7. doi: 10.1016/j.metabol.2007.01.014.
6
Estrogen treatment improves arterial distensibility, fibrinolysis, and metabolic profile in postmenopausal women with type 2 diabetes mellitus.
Metabolism. 2006 Jul;55(7):953-9. doi: 10.1016/j.metabol.2006.03.003.
7
Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.雌激素给药途径对健康绝经后女性胰岛素样生长因子-I、胰岛素样生长因子结合蛋白-3及胰岛素抵抗的影响:一项随机对照研究的结果
Menopause. 2008 Nov-Dec;15(6):1065-9. doi: 10.1097/gme.0b013e318174f16e.
8
Climacteric symptom control after the addition of low-dose esterified conjugated estrogens to raloxifene standard doses.在雷洛昔芬标准剂量基础上加用低剂量结合雌激素后的更年期症状控制。
Int J Fertil Womens Med. 2007 Mar-Jun;52(2-3):93-6.
9
Effect of estrogen therapy on insulin resistance and plasminogen activator inhibitor type 1 concentrations in postmenopausal women.雌激素疗法对绝经后女性胰岛素抵抗及纤溶酶原激活物抑制剂1浓度的影响。
Gynecol Obstet Invest. 2007;64(2):61-4. doi: 10.1159/000099148. Epub 2007 Jan 30.
10
Low and ultra low-dose estrogen therapy for climacteric symptom control--preliminary report.
Int J Fertil Womens Med. 2006 Jul-Aug;51(4):171-5.